IP Library › Granted Patent US 9,358,264
Granted Patent B2
US 9,358,264 · App. 13/072,648 · Granted Jun 7, 2016

Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism

Inventors: Alvin Ibarra (Hoboken, NJ); Marc Roller (Morieres les Avignon, FR); Jacques DiKansky (Avignon, FR)
Assignee: NATUREX, S.A.
A61K36/74A61K31/235A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,358,264
App. No.
13/072,648
Granted
Jun 7, 2016
Kind
B2
Abstract

A method of controlling body weight in humans by administering an amount of decaffeinated green coffee extract effective to treat a subject. A preferred green coffee extract contains a ratio of 4-caffeoylquinic acid (4-CQA) to total chlorogenic acids (tCGA) (5-CQA/tCGA) of from about 0.1 to about 0.2. More preferably, the green coffee extract comprises from about 6% to about 8% of 4-caffeoylquinic acid and has a total chlorogenic acid concentration that exceeds about 45%. A preferred method of administration consists of administering the green coffee extracts is a dosage of about 200 mg twice a day prior to meals on an empty stomach.

Claims (1)

1. A method of inhibiting human liver glucose-6-phosphatase system (Glc-6-Pase) activity, the method comprising administering to an overweight human subject, or to a human subject having obesity or type 2 diabetes an effective amount of a composition consisting of 4-caffeoylquinic acid (4-CQA), 5-caffeoylquinic acid (5-CQA), 3,4-dicaffeoylquinic acid (3,4-diCQA), and 4,5-dicaffeoylquinic acid (4,5-diCQA) to inhibit the human liver Glc-6-Pase activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2012
From: IBARRA, ALVIN; ROLLER, MARC; DIKANSKY, JACQUES
To: NATUREX, S.A.
Reel/Frame 028124/0565 →
Continuity (4)
Continuation In Part 12263292 · Oct 31, 2008
Related Publication 20110223281A1 · Sep 15, 2011
Related Publication 20150072042A2 · Mar 12, 2015
Related Publication 20160015766A2 · Jan 21, 2016